Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Myofibroma 3Leiomyoma 3Stomach Neoplasms 2Meningioma 2Hemorrhage 2Breast Neoplasms 2Wrist Fractures 1Seroma 1Prostatic Neoplasms 1Postoperative Hemorrhage 1Postoperative Complications 1Polyposis, Gastric 1Pancreatic Neoplasms 1Neoplasms 1Metrorrhagia 1Liver Neoplasms 1Hematoma 1Head and Neck Neoplasms 1Hand Injuries 1Glioma 1Esophageal Neoplasms 1Encephalocele 1Edema 1Dupuytren Contracture 1Duodenal Neoplasms 1Disease 1Colonic Neoplasms 1Brain Neoplasms 1Blood Loss, Surgical 1Astrocytoma 1

Interventions

Sorafenib 9Radiofrequency Ablation 7Oxaliplatin 7Fluorouracil 6Doxorubicin 6Neoadjuvant Therapy 5toripalimab 4lenvatinib 4Injections 4Chemotherapy, Adjuvant 4Bevacizumab 4sintilimab 3pembrolizumab 3Ultrasonography 3Thalidomide 3Leucovorin 3Irinotecan 3Cisplatin 3tislelizumab 2durvalumab 2camrelizumab 2anlotinib 2Walking Speed 2Standard of Care 2Radiosurgery 2Oncolytic Virotherapy 2Metformin 2Liver Transplantation 2Laparoscopy 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Liver Neoplasms × Tranexamic Acid × Clear all
NCT01655641 2012-10-16

TMGS

Tribhuvan University Teaching Hospital, Institute Of Medicine.

Phase 2/3 Unknown
118 enrolled
Gastrointestinal

Colonic Neoplasms, Hemorrhage, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡